InvestorsHub Logo
Followers 15
Posts 1855
Boards Moderated 0
Alias Born 10/18/2008

Re: None

Thursday, 06/12/2014 3:42:01 AM

Thursday, June 12, 2014 3:42:01 AM

Post# of 2191
We're talking a $8.7 Billion drug here!!

Here's the news released last night by Zalicus's partner Epirus that shows superiority over J&J's drug Remicade:

http://www.epirusbiopharma.com/investors/investors-press-releases-2014-06-11.php


And here's the Link to the market potential (scroll down the page and look for Remicade sales in 2013):

http://www.usatoday.com/story/money/markets/2013/10/22/three-best-selling-drugs/3149997/